Masahiro Rokugo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Basic-Leucine Zipper Transcription Factors | 1 | 2020 | 151 | 0.170 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2882 | 0.150 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2020 | 262 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2020 | 304 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.120 |
Why?
|
Lymph Nodes | 1 | 2024 | 3486 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1724 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2331 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8515 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5351 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 165 | 0.040 |
Why?
|
Mouth Neoplasms | 1 | 2024 | 593 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 175 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 802 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 586 | 0.030 |
Why?
|
Cadherins | 1 | 2020 | 898 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1832 | 0.030 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2019 | 421 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1110 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1741 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6828 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29658 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4000 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6544 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4902 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5206 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16939 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10181 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22023 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81208 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6465 | 0.010 |
Why?
|
Female | 5 | 2024 | 391270 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9276 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 220352 | 0.010 |
Why?
|
Fistula | 1 | 1982 | 214 | 0.010 |
Why?
|
Ear Diseases | 1 | 1982 | 177 | 0.010 |
Why?
|
Animals | 2 | 2024 | 167963 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39261 | 0.010 |
Why?
|
Aged | 2 | 2020 | 169152 | 0.010 |
Why?
|
Humans | 5 | 2024 | 760621 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13262 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58995 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
Child | 2 | 2020 | 79806 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 87810 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36290 | 0.010 |
Why?
|
Male | 3 | 2020 | 359744 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80372 | 0.010 |
Why?
|
Adult | 2 | 2020 | 219994 | 0.000 |
Why?
|
Ear, External | 1 | 1982 | 164 | 0.000 |
Why?
|
Child, Preschool | 1 | 1982 | 42063 | 0.000 |
Why?
|